,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Pneumonitis,2,16792437
1,22.1,Anaemia,2,16792437
0,22.0,Abdominal pain,6,16792466
1,22.0,Hot flush,6,16792466
2,22.0,Diarrhoea,6,16792466
3,22.0,Fatigue,6,16792466
0,22.1,Terminal state,6,16792528
1,22.1,Fatigue,6,16792528
2,22.1,Decreased appetite,6,16792528
3,22.1,Pain in extremity,6,16792528
4,22.1,Back pain,6,16792528
5,22.1,Nausea,6,16792528
0,22.0,Fungal infection,6,16792683
1,22.0,Cerebrovascular accident,3,16792683
2,22.0,Nausea,6,16792683
3,22.0,Vomiting,6,16792683
0,22.0,Haemolytic anaemia,5,16792731
1,22.0,Pyrexia,5,16792731
2,22.0,Tremor,5,16792731
3,22.0,Pulmonary embolism,5,16792731
4,22.0,Chromaturia,5,16792731
5,22.0,Malignant neoplasm progression,5,16792731
6,22.0,Paraesthesia,5,16792731
7,22.0,Metastases to peritoneum,5,16792731
0,22.0,Nausea,2,16792743
1,22.0,Decreased appetite,2,16792743
2,22.0,Hypophagia,6,16792743
3,22.0,Vomiting,2,16792743
0,22.0,Neurotoxicity,1,16792747
1,22.0,Delirium,1,16792747
2,22.0,Psychomotor hyperactivity,1,16792747
0,22.0,Colorectal cancer metastatic,5,16792761
1,22.0,Sepsis,5,16792761
2,22.0,Pneumonia,5,16792761
3,22.0,Encephalopathy,5,16792761
4,22.0,Disease progression,5,16792761
0,22.0,Cerebrovascular accident,3,16792777
0,22.0,Erysipelas,1,16792780
0,22.0,Pulmonary fibrosis,6,16792793
0,22.1,Gastrointestinal hypomotility,2,16792802
1,22.1,Dyspepsia,2,16792802
2,22.1,Hot flush,2,16792802
0,22.1,Pain in extremity,6,16792840
1,22.1,Peripheral swelling,6,16792840
2,22.1,Arthritis,6,16792840
3,22.1,Pulmonary embolism,6,16792840
4,22.1,Fatigue,6,16792840
5,22.1,Headache,3,16792840
6,22.1,Erythema,6,16792840
7,22.1,Pain,3,16792840
8,22.1,Myalgia,6,16792840
9,22.1,Depression,6,16792840
0,22.0,Death,5,16792887
0,22.0,Myocarditis,2,16792893
1,22.0,Myositis,2,16792893
0,22.0,Drug resistance,6,16792894
1,22.0,Malignant neoplasm progression,6,16792894
0,22.1,Pain,6,16792934
1,22.1,Restlessness,6,16792934
2,22.1,Nausea,6,16792934
3,22.1,Anxiety,6,16792934
4,22.1,Abdominal pain upper,1,16792934
5,22.1,Pleural effusion,1,16792934
6,22.1,Weight decreased,2,16792934
7,22.1,Fatigue,2,16792934
8,22.1,Empyema,2,16792934
0,22.0,Malignant neoplasm progression,6,16792935
1,22.0,Drug resistance,6,16792935
0,22.0,Malignant neoplasm progression,6,16792936
1,22.0,Drug resistance,6,16792936
0,22.1,Lung carcinoma cell type unspecified stage IV,5,16792939
1,22.1,Fall,6,16792939
2,22.1,Upper limb fracture,6,16792939
0,22.0,Blood calcium decreased,2,16792945
0,22.0,Pneumonitis,5,16792947
1,22.0,Pneumonia,5,16792947
0,22.0,Malignant neoplasm progression,6,16792958
1,22.0,Drug resistance,6,16792958
0,22.0,Malignant neoplasm progression,6,16792959
1,22.0,Drug resistance,6,16792959
0,22.0,Rash papular,1,16792969
0,22.1,Neuropathy peripheral,2,16792988
1,22.1,Arthritis,2,16792988
0,22.0,Malignant neoplasm progression,6,16793006
1,22.0,Drug resistance,6,16793006
0,22.0,Prostate cancer,5,16793016
0,22.1,Pneumonia aspiration,2,16793022
1,22.1,Hypothyroidism,1,16793022
2,22.1,Hypopituitarism,1,16793022
0,22.1,Device battery issue,6,16793042
1,22.1,Off label use,6,16793042
0,22.0,Malignant neoplasm progression,6,16793048
1,22.0,Drug resistance,6,16793048
0,22.0,Drug resistance,6,16793064
1,22.0,Malignant neoplasm progression,6,16793064
0,22.1,Neutrophil count decreased,2,16793118
1,22.1,Stomatitis,3,16793118
2,22.1,Pruritus,3,16793118
3,22.1,Taste disorder,6,16793118
4,22.1,Rash,3,16793118
5,22.1,Neutrophil count decreased,2,16793118
6,22.1,Alopecia,3,16793118
7,22.1,Malaise,6,16793118
0,22.1,Malignant neoplasm progression,6,16793119
1,22.1,Drug resistance,6,16793119
0,22.1,Polyneuropathy,2,16793138
0,22.0,Off label use,2,16793140
1,22.0,Deafness,3,16793140
0,22.0,Malignant neoplasm progression,6,16793142
1,22.0,Drug resistance,6,16793142
0,22.0,Ischaemic cardiomyopathy,3,16793143
1,22.0,Atrial fibrillation,3,16793143
2,22.0,Coronary artery disease,3,16793143
3,22.0,Off label use,6,16793143
4,22.0,Coronary artery occlusion,3,16793143
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16793143
6,22.0,Chronic left ventricular failure,3,16793143
0,22.0,Immune thrombocytopenic purpura,3,16793166
1,22.0,Condition aggravated,3,16793166
2,22.0,Thrombocytopenia,3,16793166
0,22.0,Feeling hot,1,16793180
1,22.0,Cough,1,16793180
2,22.0,Throat tightness,1,16793180
0,22.0,Skin ulcer,6,16793190
1,22.0,Alopecia,6,16793190
2,22.0,Asthenia,6,16793190
3,22.0,Confusional state,6,16793190
4,22.0,Dehydration,6,16793190
5,22.0,Diverticulitis,6,16793190
0,22.0,Blood calcium decreased,2,16793216
0,22.0,Jaundice cholestatic,2,16793221
0,22.0,Pleural effusion,6,16793228
1,22.0,Malignant neoplasm progression,6,16793228
2,22.0,Drug resistance,6,16793228
0,22.0,Vomiting,1,16793240
1,22.0,Nausea,1,16793240
2,22.0,Jaundice,2,16793240
3,22.0,Diarrhoea,1,16793240
0,22.0,Oesophageal varices haemorrhage,1,16793343
0,22.1,Bronchiectasis,1,16793409
1,22.1,Eczema,2,16793409
0,22.0,Diarrhoea,6,16793430
0,22.1,Haemoptysis,5,16793458
1,22.1,Obstructive airways disorder,5,16793458
2,22.1,Endocarditis,6,16793458
3,22.1,Diarrhoea,6,16793458
4,22.1,Bacteraemia,2,16793458
5,22.1,Pyrexia,1,16793458
6,22.1,Dyspnoea,6,16793458
7,22.1,Tumour pseudoprogression,6,16793458
8,22.1,Off label use,6,16793458
0,22.1,Fall,6,16793494
1,22.1,Death,5,16793494
2,22.1,Intentional product use issue,6,16793494
3,22.1,Off label use,6,16793494
4,22.1,Hip fracture,6,16793494
0,22.0,Liver disorder,5,16793535
0,22.0,Hepatitis acute,2,16793555
0,22.0,Metastases to liver,6,16793561
1,22.0,Drug resistance,6,16793561
2,22.0,Colorectal cancer metastatic,6,16793561
0,22.0,Metastases to bone,6,16793595
1,22.0,Malignant neoplasm progression,6,16793595
2,22.0,Breast cancer,6,16793595
0,22.1,Infusion related reaction,1,16793626
1,22.1,Erythema,1,16793626
0,22.0,Pneumonitis,5,16793647
0,22.0,Drug resistance,6,16793679
1,22.0,Malignant neoplasm progression,6,16793679
0,22.0,Pain in jaw,1,16793687
1,22.0,Oral cavity fistula,1,16793687
2,22.0,Osteonecrosis of jaw,1,16793687
3,22.0,Exostosis of jaw,1,16793687
4,22.0,Exposed bone in jaw,1,16793687
5,22.0,Sequestrectomy,1,16793687
0,22.0,Death,5,16793774
1,22.0,Constipation,6,16793774
2,22.0,Abdominal pain,6,16793774
3,22.0,Diarrhoea,6,16793774
4,22.0,Asthenia,6,16793774
0,22.0,Drug resistance,6,16793795
1,22.0,Malignant neoplasm progression,6,16793795
0,22.0,Malignant neoplasm progression,6,16793802
1,22.0,Drug resistance,6,16793802
0,22.1,Pulmonary arterial hypertension,2,16793824
0,22.1,Drug ineffective,6,16793878
1,22.1,Diarrhoea,3,16793878
2,22.1,Nerve compression,3,16793878
3,22.1,Mobility decreased,6,16793878
4,22.1,Headache,3,16793878
5,22.1,Malignant neoplasm progression,5,16793878
6,22.1,Drug resistance,6,16793878
0,22.0,Productive cough,3,16793920
0,22.0,Rash,2,16793948
0,22.0,Haematotoxicity,1,16793978
0,22.0,Pancreatitis relapsing,6,16794024
0,22.0,Drug resistance,6,16794037
1,22.0,Malignant neoplasm progression,6,16794037
0,22.0,Nasopharyngitis,6,16794053
0,22.0,Hair texture abnormal,3,16794061
0,22.0,No adverse event,6,16794062
1,22.0,Intentional product use issue,6,16794062
2,22.0,Off label use,6,16794062
0,22.0,Pregnancy,6,16794064
1,22.0,No adverse event,6,16794064
0,22.1,Joint swelling,6,16794069
1,22.1,Arthralgia,6,16794069
2,22.1,Abdominal discomfort,6,16794069
3,22.1,Constipation,6,16794069
4,22.1,Platelet count abnormal,3,16794069
5,22.1,Rheumatoid arthritis,6,16794069
6,22.1,Fatigue,3,16794069
7,22.1,Joint stiffness,6,16794069
8,22.1,Emotional distress,6,16794069
9,22.1,Tearfulness,6,16794069
10,22.1,Platelet count decreased,1,16794069
11,22.1,Anaemia,3,16794069
12,22.1,Myalgia,6,16794069
13,22.1,Nausea,1,16794069
14,22.1,Pain in jaw,2,16794069
15,22.1,Abdominal pain upper,1,16794069
16,22.1,Feeding disorder,6,16794069
0,22.0,Weight increased,6,16794087
0,22.1,Diarrhoea,6,16794104
1,22.1,Renal impairment,3,16794104
2,22.1,Adrenal disorder,3,16794104
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16794106
1,22.0,Rash maculo-papular,3,16794106
2,22.0,Pruritus,3,16794106
3,22.0,Rash pruritic,3,16794106
4,22.0,Pain in extremity,6,16794106
5,22.0,Dermatitis acneiform,3,16794106
6,22.0,Neuropathy peripheral,3,16794106
0,22.1,Mobility decreased,3,16794111
1,22.1,Fall,6,16794111
2,22.1,Rehabilitation therapy,6,16794111
3,22.1,Contusion,3,16794111
4,22.1,Joint dislocation,3,16794111
5,22.1,Fall,1,16794111
0,22.1,Hot flush,2,16794149
1,22.1,Gastrointestinal hypomotility,2,16794149
2,22.1,Dyspepsia,2,16794149
0,22.0,Acute kidney injury,1,16794180
1,22.0,Diarrhoea,1,16794180
0,22.0,Neuropathy peripheral,3,16794183
0,22.0,Constipation,2,16794208
1,22.0,Blood pressure increased,2,16794208
2,22.0,Abdominal pain,2,16794208
3,22.0,Dry skin,3,16794208
4,22.0,Back pain,1,16794208
5,22.0,Headache,3,16794208
6,22.0,Gallbladder disorder,2,16794208
0,22.0,Immune thrombocytopenic purpura,6,16794218
0,22.0,Death,5,16794256
0,22.0,Supraventricular tachycardia,1,16794259
1,22.0,Diarrhoea,3,16794259
0,22.0,Dyspnoea,6,16794263
0,22.0,Febrile neutropenia,3,16794268
1,22.0,Cardio-respiratory arrest,5,16794268
2,22.0,Sepsis,3,16794268
0,22.0,Liver function test increased,6,16794274
0,22.0,Myalgia,6,16794276
0,22.0,Fluid retention,6,16794302
1,22.0,Dyspnoea,3,16794302
2,22.0,Bradycardia,6,16794302
0,22.0,Blood creatine phosphokinase increased,1,16794304
0,22.0,Blood bilirubin increased,6,16794312
0,22.0,Haematocrit decreased,3,16794314
1,22.0,Blood count abnormal,3,16794314
2,22.0,Blood phosphorus decreased,3,16794314
3,22.0,Transferrin decreased,3,16794314
4,22.0,Protein total decreased,3,16794314
5,22.0,Haemoglobin decreased,3,16794314
6,22.0,Iron binding capacity total decreased,3,16794314
0,22.0,Breast cancer,2,16794341
1,22.0,Hypersensitivity,6,16794341
2,22.0,Malignant neoplasm progression,2,16794341
0,22.0,Malignant neoplasm progression,6,16794343
1,22.0,Drug resistance,6,16794343
0,22.0,Drug resistance,6,16794345
1,22.0,Malignant neoplasm progression,6,16794345
0,22.0,Malignant neoplasm progression,6,16794364
1,22.0,Metastases to central nervous system,6,16794364
2,22.0,Breast cancer,6,16794364
0,22.0,Non-cardiac chest pain,1,16794399
1,22.0,Dyspnoea,1,16794399
0,22.0,Rash,6,16794412
1,22.0,Pruritus,6,16794412
2,22.0,Loss of consciousness,6,16794412
3,22.0,Fatigue,6,16794412
0,22.1,Malignant neoplasm progression,6,16794415
1,22.1,Breast cancer stage IV,6,16794415
2,22.1,Dyspnoea,4,16794415
3,22.1,Cough,6,16794415
0,22.0,White blood cell count decreased,6,16794431
0,22.0,Stomatitis,6,16794437
0,22.1,Feeling abnormal,6,16794440
1,22.1,Movement disorder,2,16794440
2,22.1,Thinking abnormal,1,16794440
3,22.1,Nervous system disorder,6,16794440
4,22.1,Product dose omission,6,16794440
5,22.1,Blood sodium decreased,2,16794440
6,22.1,Pain,1,16794440
7,22.1,Back pain,6,16794440
8,22.1,Delusion,6,16794440
9,22.1,Hypertension,2,16794440
10,22.1,Malaise,6,16794440
11,22.1,Aphonia,6,16794440
12,22.1,Feeling abnormal,1,16794440
13,22.1,Fatigue,3,16794440
0,22.0,Diarrhoea,2,16794448
1,22.0,Nausea,2,16794448
2,22.0,Product use in unapproved indication,6,16794448
0,22.1,Death,,16794460
0,22.0,Malignant neoplasm progression,6,16794506
1,22.0,Drug resistance,6,16794506
0,22.0,Cardiomyopathy,6,16794511
1,22.0,Cardiac failure congestive,3,16794511
0,22.1,Enterocolitis,6,16794514
1,22.1,Nausea,2,16794514
2,22.1,Neutrophil count decreased,2,16794514
3,22.1,Malignant neoplasm progression,5,16794514
4,22.1,Pancytopenia,2,16794514
5,22.1,Stomatitis,1,16794514
0,22.0,Bone marrow failure,1,16794525
0,22.0,Photosensitivity reaction,6,16794541
1,22.0,Pain in extremity,6,16794541
0,22.0,Malignant neoplasm progression,6,16794563
1,22.0,Drug resistance,6,16794563
0,22.0,Blood pressure increased,3,16794595
1,22.0,Dental caries,6,16794595
2,22.0,Diarrhoea,3,16794595
3,22.0,Osteonecrosis of jaw,6,16794595
4,22.0,Urinary tract infection,1,16794595
0,22.1,Disease progression,,16794603
0,22.1,Immune-mediated hepatitis,1,16794611
1,22.1,Arthralgia,2,16794611
2,22.1,Febrile neutropenia,1,16794611
3,22.1,Hyperthyroidism,3,16794611
4,22.1,Blood thyroid stimulating hormone increased,2,16794611
5,22.1,Dizziness,6,16794611
0,22.1,Fall,6,16794650
1,22.1,Femur fracture,6,16794650
0,22.1,Ulcerative keratitis,2,16794668
1,22.1,Stevens-Johnson syndrome,2,16794668
2,22.1,Staphylococcal infection,6,16794668
0,22.1,Neoplasm progression,6,16794693
0,22.1,Memory impairment,6,16794725
1,22.1,Fatigue,6,16794725
2,22.1,Visual impairment,6,16794725
3,22.1,Back pain,6,16794725
4,22.1,Alopecia,6,16794725
5,22.1,Muscle spasms,6,16794725
6,22.1,Back disorder,6,16794725
0,22.0,Wrong technique in product usage process,6,16794735
1,22.0,Hypertension,6,16794735
0,22.0,Fatigue,6,16794767
0,22.1,Cholelithiasis,1,16794862
0,22.0,Thrombocytopenia,6,16794870
1,22.0,Leukaemia,5,16794870
0,22.0,Arteriospasm coronary,4,16794881
1,22.0,Infarction,4,16794881
0,22.1,Disease progression,,16794912
0,22.0,Pyrexia,6,16794927
0,22.1,Neoplasm progression,6,16794931
1,22.1,Insomnia,6,16794931
2,22.1,Alopecia,6,16794931
3,22.1,Fatigue,6,16794931
0,22.1,Nausea,,16794944
0,22.1,Malignant neoplasm progression,6,16794953
0,22.0,Neoplasm recurrence,6,16795045
1,22.0,Neutropenia,6,16795045
0,22.0,Oedema peripheral,3,16795056
1,22.0,Arthralgia,3,16795056
2,22.0,Pancreatitis,6,16795056
3,22.0,Gallbladder disorder,1,16795056
0,22.0,Terminal state,6,16795076
0,22.0,Neoplasm progression,6,16795192
1,22.0,Skin cancer,1,16795192
2,22.0,Second primary malignancy,1,16795192
0,22.1,Rib fracture,3,16795216
1,22.1,Dementia Alzheimer^s type,6,16795216
2,22.1,Dementia,6,16795216
0,22.1,Cutaneous lupus erythematosus,2,16795220
0,22.0,Cardiomyopathy,6,16795225
0,22.1,Dry eye,3,16795226
1,22.1,Yellow skin,3,16795226
2,22.1,Ageusia,3,16795226
3,22.1,Skin exfoliation,3,16795226
4,22.1,Oropharyngeal pain,3,16795226
5,22.1,Tongue discomfort,3,16795226
6,22.1,Penile swelling,1,16795226
7,22.1,Dry skin,3,16795226
8,22.1,Wound,3,16795226
9,22.1,Skin swelling,3,16795226
10,22.1,Tongue injury,3,16795226
11,22.1,Skin atrophy,3,16795226
12,22.1,Decreased immune responsiveness,3,16795226
13,22.1,Weight decreased,3,16795226
14,22.1,Limb injury,3,16795226
0,22.0,Hypertension,3,16795236
1,22.0,Impaired healing,3,16795236
2,22.0,Infected skin ulcer,3,16795236
0,22.1,Drug-induced liver injury,1,16795248
1,22.1,Hepatic function abnormal,3,16795248
0,22.0,Drug resistance,6,16795250
1,22.0,Malignant neoplasm progression,6,16795250
0,22.0,Off label use,6,16795262
1,22.0,Product use in unapproved indication,6,16795262
2,22.0,Acute coronary syndrome,2,16795262
0,22.0,Toxicity to various agents,6,16795284
1,22.0,Ototoxicity,6,16795284
2,22.0,Off label use,6,16795284
3,22.0,Infected lymphocele,6,16795284
4,22.0,Product use in unapproved indication,6,16795284
0,22.0,Drug ineffective,6,16795321
1,22.0,Cushing^s syndrome,1,16795321
2,22.0,Prostate cancer,5,16795321
3,22.0,Neuroendocrine tumour,5,16795321
0,22.1,Pain,3,16795349
1,22.1,Peripheral swelling,3,16795349
2,22.1,Upper limb fracture,3,16795349
3,22.1,Limb injury,6,16795349
4,22.1,Malaise,6,16795349
5,22.1,Blood pressure abnormal,3,16795349
0,22.0,Interstitial lung disease,6,16795415
1,22.0,Neutrophil count decreased,6,16795415
2,22.0,Anaemia,6,16795415
0,22.0,Blood potassium increased,3,16795434
0,22.0,Rash maculo-papular,2,16795489
1,22.0,Hepatocellular injury,3,16795489
0,22.1,Muscular weakness,6,16795490
1,22.1,Loss of consciousness,1,16795490
2,22.1,Condition aggravated,1,16795490
3,22.1,Dysstasia,1,16795490
0,22.0,Disease progression,5,16795507
0,22.1,Chronic respiratory failure,6,16795517
1,22.1,Metastases to the mediastinum,6,16795517
2,22.1,Interstitial lung disease,4,16795517
0,22.0,Interstitial lung disease,1,16795534
1,22.0,Aortic arteriosclerosis,6,16795534
0,22.0,Hypertriglyceridaemia,1,16795537
0,22.0,Pruritus,2,16795577
1,22.0,Erythema,2,16795577
0,22.0,Diarrhoea,2,16795589
1,22.0,Melaena,2,16795589
0,22.0,Neutrophil percentage increased,2,16795596
0,22.1,Small intestinal obstruction,1,16795696
1,22.1,Pyrexia,6,16795696
2,22.1,Cystitis haemorrhagic,1,16795696
3,22.1,Arthritis,6,16795696
4,22.1,Autoimmune colitis,1,16795696
5,22.1,Pulmonary embolism,6,16795696
6,22.1,Colitis,6,16795696
7,22.1,Off label use,6,16795696
8,22.1,Adrenal insufficiency,1,16795696
0,22.0,Pneumocystis jirovecii pneumonia,2,16795697
1,22.0,Malignant neoplasm progression,6,16795697
2,22.0,Cytomegalovirus infection,2,16795697
0,22.1,Neutrophil count decreased,1,16795715
0,22.0,Malignant neoplasm progression,6,16795717
1,22.0,Drug resistance,6,16795717
0,22.0,Pneumonia aspiration,2,16795750
0,22.0,Drug ineffective,6,16795755
1,22.0,Ovarian cancer recurrent,6,16795755
0,22.0,Intentional product use issue,6,16795785
1,22.0,Malignant neoplasm progression,6,16795785
2,22.0,Asthenia,6,16795785
3,22.0,Abdominal pain upper,6,16795785
0,22.0,Drug resistance,6,16795826
1,22.0,Pyrexia,6,16795826
2,22.0,Malignant neoplasm progression,6,16795826
3,22.0,Hepatic function abnormal,6,16795826
0,22.0,Malignant neoplasm progression,6,16795827
1,22.0,Drug resistance,6,16795827
0,22.1,Neoplasm progression,6,16795830
1,22.1,Fatigue,3,16795830
0,22.0,Full blood count abnormal,6,16795837
0,22.1,Confusional state,6,16795843
0,22.1,Pancytopenia,1,16795871
1,22.1,Breast cancer metastatic,3,16795871
0,22.1,Muscular weakness,6,16795876
1,22.1,Adverse event,6,16795876
2,22.1,Nausea,6,16795876
0,22.0,Proctitis,6,16795888
0,22.1,Febrile neutropenia,1,16795899
1,22.1,Off label use,6,16795899
0,22.0,Herpes virus infection,6,16795969
1,22.0,Mass,6,16795969
2,22.0,Malignant neoplasm progression,6,16795969
3,22.0,Drug resistance,6,16795969
0,22.0,Brain death,6,16795974
1,22.0,Leukopenia,1,16795974
2,22.0,Cerebral infarction,6,16795974
3,22.0,Thrombocytopenia,1,16795974
0,22.0,Hyponatraemia,1,16795976
0,22.0,Stomatitis,1,16795990
1,22.0,Product use in unapproved indication,2,16795990
2,22.0,Gastric disorder,2,16795990
3,22.0,Back pain,1,16795990
4,22.0,Blood pressure fluctuation,3,16795990
5,22.0,Chest pain,1,16795990
6,22.0,Arthralgia,2,16795990
7,22.0,Rash,1,16795990
8,22.0,Glossodynia,3,16795990
0,22.0,Death,5,16796018
0,22.0,Death,5,16796050
1,22.0,Pneumonia,6,16796050
2,22.0,Malignant neoplasm progression,6,16796050
3,22.0,Encephalopathy,6,16796050
4,22.0,Sepsis,6,16796050
5,22.0,Metastases to central nervous system,6,16796050
0,22.1,Haemoglobin decreased,1,16796094
1,22.1,Blood glucose increased,2,16796094
2,22.1,Platelet count decreased,1,16796094
3,22.1,Nausea,1,16796094
4,22.1,White blood cell count decreased,1,16796094
5,22.1,Pyelonephritis,1,16796094
6,22.1,Septic shock,1,16796094
0,22.0,Arthropathy,3,16796146
1,22.0,Thrombocytopenia,3,16796146
2,22.0,Renal failure,3,16796146
0,22.1,Bronchitis,6,16796192
0,22.0,Chills,1,16796231
1,22.0,Pyrexia,1,16796231
0,22.0,Weight decreased,,16796268
1,22.0,Fatigue,,16796268
2,22.0,Dysphonia,,16796268
3,22.0,Diarrhoea,,16796268
4,22.0,Pain in extremity,,16796268
0,22.0,Cerebrovascular accident,3,16796274
0,22.0,General physical health deterioration,2,16796280
0,22.0,Hypothalamo-pituitary disorder,3,16796349
0,22.0,Meningitis herpes,2,16796358
0,22.1,Hepatobiliary disease,2,16796386
1,22.1,Bile duct obstruction,2,16796386
0,22.0,Pleural effusion,6,16796387
0,22.0,Psychological trauma,6,16796410
1,22.0,Alopecia,2,16796410
0,22.0,Diverticulitis,5,16796423
1,22.0,Sepsis,5,16796423
2,22.0,Intestinal perforation,5,16796423
0,22.0,Decreased appetite,6,16796583
1,22.0,Diarrhoea,6,16796583
2,22.0,Asthenia,6,16796583
3,22.0,Vomiting,6,16796583
4,22.0,Disorientation,6,16796583
0,22.0,Thinking abnormal,6,16796614
1,22.0,Headache,3,16796614
2,22.0,Nausea,6,16796614
3,22.0,Toxicity to various agents,6,16796614
4,22.0,Influenza like illness,6,16796614
5,22.0,Weight decreased,6,16796614
6,22.0,Adverse event,6,16796614
7,22.0,Vomiting,6,16796614
0,22.0,Insomnia,3,16796616
0,22.1,Off label use,6,16796618
1,22.1,Incorrect dose administered,6,16796618
2,22.1,Liver disorder,1,16796618
0,22.1,Drug ineffective,2,16796626
0,22.0,Fatigue,6,16796631
0,22.0,Fatigue,2,16796640
1,22.0,Thermal burn,1,16796640
2,22.0,Fall,1,16796640
0,22.1,Pain,3,16796645
1,22.1,Headache,3,16796645
2,22.1,Malaise,6,16796645
3,22.1,Headache,6,16796645
0,22.1,Therapeutic product effect incomplete,6,16796665
1,22.1,Malignant neoplasm progression,2,16796665
2,22.1,Cancer pain,6,16796665
0,22.1,Hepatic cyst,6,16796677
1,22.1,Colitis,6,16796677
2,22.1,Pleural effusion,6,16796677
3,22.1,Hydronephrosis,6,16796677
4,22.1,Rectal cancer stage II,6,16796677
5,22.1,BRAF V600E mutation positive,6,16796677
6,22.1,Metastases to liver,6,16796677
7,22.1,Skin reaction,6,16796677
8,22.1,Rectal cancer,6,16796677
9,22.1,Malignant neoplasm progression,6,16796677
10,22.1,Intestinal metastasis,6,16796677
11,22.1,Ileus,6,16796677
12,22.1,Lymphadenopathy,6,16796677
13,22.1,Pulmonary mass,6,16796677
14,22.1,Cholestasis,6,16796677
0,22.0,Retinal vein thrombosis,6,16796723
1,22.0,Retinal haemorrhage,6,16796723
2,22.0,Visual impairment,6,16796723
0,22.0,Death,5,16796738
1,22.0,Urinary tract infection,6,16796738
2,22.0,Weight decreased,6,16796738
0,22.0,Death,5,16796739
0,22.0,Fatigue,3,16796745
1,22.0,Myocardial infarction,6,16796745
2,22.0,Stomatitis,6,16796745
0,22.0,Fall,6,16796746
1,22.0,Concussion,6,16796746
2,22.0,Drug ineffective,6,16796746
0,22.0,Oedema peripheral,6,16796747
1,22.0,Product dose omission,6,16796747
0,22.0,Bladder cancer recurrent,6,16796753
0,22.0,Malignant neoplasm progression,6,16796769
1,22.0,Drug resistance,6,16796769
0,22.1,Death,5,16796797
1,22.1,Pneumonia,2,16796797
2,22.1,Malignant neoplasm progression,6,16796797
0,22.1,Abscess limb,1,16796853
1,22.1,Haematoma,6,16796853
0,22.0,Oral candidiasis,6,16796862
0,22.1,Hepatic enzyme increased,1,16796915
0,22.1,Pancytopenia,5,16796952
1,22.1,Aplastic anaemia,5,16796952
0,22.1,Colon cancer,5,16796956
1,22.1,Disease progression,5,16796956
2,22.1,Ascites,5,16796956
0,22.1,Osteonecrosis of jaw,3,16796962
1,22.1,Death,5,16796962
2,22.1,Hypocalcaemia,6,16796962
3,22.1,Dermatomyositis,6,16796962
0,22.0,Drug resistance,6,16796967
1,22.0,Malignant neoplasm progression,6,16796967
0,22.1,Malignant neoplasm progression,6,16796968
1,22.1,Drug resistance,6,16796968
0,22.0,Bone marrow failure,1,16796977
0,22.0,Product use in unapproved indication,6,16796981
0,22.0,Platelet count decreased,2,16797109
1,22.0,Eye inflammation,1,16797109
2,22.0,Dysphagia,1,16797109
3,22.0,Haemoglobin decreased,2,16797109
4,22.0,Viral pharyngitis,1,16797109
0,22.0,Drug resistance,6,16797133
1,22.0,Malignant neoplasm progression,6,16797133
0,22.1,Osteonecrosis of jaw,6,16797139
1,22.1,Subcutaneous abscess,2,16797139
2,22.1,Osteomyelitis,2,16797139
0,22.0,Chest pain,1,16797140
1,22.0,Paronychia,1,16797140
2,22.0,Pyrexia,1,16797140
3,22.0,Neutrophil count decreased,1,16797140
4,22.0,Dermatitis acneiform,1,16797140
5,22.0,Hypomagnesaemia,1,16797140
0,22.1,Malignant neoplasm progression,5,16797180
0,22.1,Disease progression,5,16797184
1,22.1,Back pain,2,16797184
0,22.1,Gastrointestinal haemorrhage,6,16797219
1,22.1,Nausea,1,16797219
2,22.1,Anaemia,1,16797219
3,22.1,Decreased appetite,1,16797219
4,22.1,Diarrhoea,1,16797219
5,22.1,General physical health deterioration,5,16797219
0,22.0,Gastric ulcer,6,16797254
1,22.0,Haemoglobin decreased,6,16797254
2,22.0,Gastrointestinal haemorrhage,1,16797254
3,22.0,Oesophagitis,3,16797254
4,22.0,Gastritis erosive,3,16797254
5,22.0,Cardioactive drug level decreased,6,16797254
6,22.0,Haematemesis,6,16797254
7,22.0,International normalised ratio abnormal,6,16797254
8,22.0,International normalised ratio decreased,6,16797254
9,22.0,International normalised ratio abnormal,1,16797254
10,22.0,Haemodynamic instability,1,16797254
11,22.0,Rectal haemorrhage,6,16797254
12,22.0,Drug interaction,6,16797254
13,22.0,Enzyme induction,6,16797254
14,22.0,Drug level decreased,6,16797254
15,22.0,Drug interaction,6,16797254
16,22.0,Drug ineffective,6,16797254
17,22.0,Venous thrombosis,6,16797254
0,22.0,Limb deformity,6,16797259
0,22.1,Dysphagia,3,16797264
1,22.1,Diarrhoea,3,16797264
2,22.1,Stomatitis,3,16797264
3,22.1,Paronychia,3,16797264
0,22.0,Protein urine present,3,16797310
1,22.0,Diarrhoea,3,16797310
2,22.0,Oral pain,3,16797310
3,22.0,Lung infection,3,16797310
4,22.0,Intestinal perforation,3,16797310
5,22.0,Blood pressure increased,3,16797310
6,22.0,Constipation,3,16797310
7,22.0,Muscle spasms,3,16797310
8,22.0,Arthralgia,3,16797310
9,22.0,Anxiety,3,16797310
0,22.0,Nausea,6,16797345
1,22.0,Chest pain,6,16797345
2,22.0,Metastases to liver,6,16797345
0,22.0,Chest discomfort,2,16797356
1,22.0,Back pain,2,16797356
2,22.0,Asphyxia,2,16797356
3,22.0,Hyperhidrosis,2,16797356
0,22.0,Drug resistance,6,16797384
0,22.1,Malignant neoplasm progression,6,16797455
1,22.1,Breast cancer female,6,16797455
2,22.1,Diarrhoea,6,16797455
0,22.0,Rash,6,16797457
0,22.0,Device related infection,1,16797458
0,22.0,Akathisia,1,16797480
1,22.0,Pain,1,16797480
0,22.1,Epilepsy,6,16797593
1,22.1,Loss of consciousness,6,16797593
0,22.1,Malignant neoplasm progression,5,16797644
0,22.0,Diarrhoea,2,16797700
1,22.0,Acute kidney injury,2,16797700
0,22.0,Malignant neoplasm progression,6,16797705
1,22.0,Drug resistance,6,16797705
0,22.0,Malignant neoplasm progression,6,16797730
1,22.0,Drug resistance,6,16797730
0,22.0,Bone marrow failure,6,16797736
1,22.0,Decreased appetite,6,16797736
0,22.0,Drug resistance,6,16797786
1,22.0,Acquired gene mutation,6,16797786
2,22.0,Colorectal cancer metastatic,6,16797786
0,22.0,Colorectal cancer metastatic,6,16797787
1,22.0,Metastases to liver,6,16797787
2,22.0,Drug resistance,6,16797787
3,22.0,K-ras gene mutation,6,16797787
0,22.0,Colorectal cancer metastatic,6,16797812
1,22.0,Drug resistance,6,16797812
2,22.0,Acquired gene mutation,6,16797812
0,22.0,Malignant neoplasm progression,6,16797816
1,22.0,Gene mutation,6,16797816
2,22.0,Metastases to central nervous system,6,16797816
3,22.0,Drug resistance,6,16797816
0,22.0,Device adhesion issue,6,16797821
1,22.0,Hyperhidrosis,6,16797821
0,22.0,Pruritus,3,16797841
1,22.0,Rash,3,16797841
0,22.0,Pneumonitis,3,16797857
0,22.1,Malignant neoplasm progression,5,16797861
0,22.0,Respiratory failure,2,16797881
1,22.0,Lymphangioleiomyomatosis,2,16797881
0,22.1,Interstitial lung disease,5,16797919
1,22.1,Off label use,6,16797919
0,22.0,Pancreatitis acute,1,16797960
1,22.0,Drug hypersensitivity,6,16797960
0,22.0,Polyneuropathy,6,16797994
0,22.1,Hypophagia,2,16797995
1,22.1,Hypotension,6,16797995
2,22.1,Blood potassium decreased,6,16797995
3,22.1,Protein total decreased,6,16797995
4,22.1,Mobility decreased,6,16797995
5,22.1,Nausea,2,16797995
6,22.1,Asthenia,6,16797995
7,22.1,Weight decreased,6,16797995
8,22.1,Loss of consciousness,6,16797995
9,22.1,Tachycardia,6,16797995
10,22.1,Peptic ulcer,6,16797995
11,22.1,Diarrhoea,6,16797995
12,22.1,Colitis,6,16797995
13,22.1,Blood albumin decreased,6,16797995
14,22.1,Urine leukocyte esterase positive,6,16797995
15,22.1,Vomiting,6,16797995
16,22.1,Decreased appetite,6,16797995
0,22.0,Metastasis,2,16798072
0,22.0,Myalgia,2,16798082
1,22.0,Pain,2,16798082
2,22.0,Product use issue,6,16798082
0,22.0,Malaise,1,16798102
1,22.0,Decreased appetite,1,16798102
2,22.0,C-reactive protein increased,2,16798102
0,22.1,Chills,6,16798115
1,22.1,Pyrexia,2,16798115
2,22.1,Rash,2,16798115
3,22.1,Malignant neoplasm progression,5,16798115
4,22.1,Asthma,6,16798115
5,22.1,Urinary tract infection,6,16798115
0,22.0,Drug resistance,6,16798210
1,22.0,Malignant neoplasm progression,6,16798210
2,22.0,Proteinuria,1,16798210
0,22.0,Flushing,1,16798236
1,22.0,Infusion related reaction,1,16798236
0,22.0,Product dose omission,6,16798269
1,22.0,No adverse event,6,16798269
0,22.0,Myelodysplastic syndrome,3,16798295
1,22.0,Thrombocytopenia,6,16798295
0,22.0,Multiple organ dysfunction syndrome,5,16798297
1,22.0,Pneumocystis jirovecii pneumonia,6,16798297
2,22.0,Respiratory failure,6,16798297
0,22.1,Fatigue,,16798298
0,22.1,Death,,16798310
0,22.1,Death,,16798341
0,22.0,Malignant neoplasm progression,6,16798358
1,22.0,Drug resistance,6,16798358
0,22.1,Hospice care,,16798403
0,22.0,Acute myeloid leukaemia,6,16798541
0,22.1,Interstitial lung disease,2,16798553
0,22.1,Death,,16798577
0,22.0,Tympanic membrane disorder,3,16798580
1,22.0,Deafness,3,16798580
2,22.0,Tinnitus,3,16798580
0,22.0,Drug resistance,6,16798587
0,22.0,Drug resistance,6,16798592
1,22.0,Malignant neoplasm progression,6,16798592
0,22.0,Nausea,3,16798594
1,22.0,Muscle spasms,6,16798594
2,22.0,Back pain,3,16798594
3,22.0,Dizziness,3,16798594
4,22.0,Abdominal pain,3,16798594
5,22.0,Intentional product misuse,6,16798594
6,22.0,Decreased appetite,3,16798594
0,22.0,Drug resistance,6,16798600
1,22.0,Malignant neoplasm progression,6,16798600
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,,16798609
0,22.1,Death,,16798628
0,22.0,Hypoglycaemia,1,16798640
0,22.0,Hypersensitivity,6,16798641
1,22.0,Pancreatitis acute,1,16798641
0,22.0,Pneumocystis jirovecii pneumonia,5,16798659
1,22.0,Respiratory failure,5,16798659
2,22.0,Multiple organ dysfunction syndrome,5,16798659
3,22.0,Drug ineffective,5,16798659
0,22.0,Lower respiratory tract infection,1,16798671
0,22.0,Constipation,3,16798672
1,22.0,Oedema,3,16798672
2,22.0,Renal impairment,6,16798672
3,22.0,Abdominal pain upper,3,16798672
4,22.0,Kidney infection,1,16798672
0,22.1,Myocardial infarction,4,16798673
0,22.0,Pneumonia,1,16798694
1,22.0,Anaemia,1,16798694
2,22.0,Blood creatinine increased,2,16798694
3,22.0,Taste disorder,3,16798694
4,22.0,Bronchitis,1,16798694
0,22.0,Sepsis,5,16798695
0,22.0,Portal hypertension,6,16798709
1,22.0,Hepatic cirrhosis,6,16798709
0,22.0,Malignant neoplasm progression,6,16798787
1,22.0,Drug resistance,6,16798787
0,22.0,Gait disturbance,6,16798789
1,22.0,Malignant neoplasm progression,6,16798789
2,22.0,Drug resistance,6,16798789
0,22.0,Metastases to liver,6,16798790
0,22.1,Acute kidney injury,6,16798813
1,22.1,Decreased appetite,2,16798813
2,22.1,Urinary tract infection,6,16798813
0,22.0,Interstitial lung disease,3,16798946
1,22.0,Angina pectoris,6,16798946
2,22.0,Decreased appetite,6,16798946
3,22.0,Pyrexia,6,16798946
4,22.0,Night sweats,6,16798946
0,22.0,Drug resistance,6,16798951
1,22.0,Malignant neoplasm progression,6,16798951
0,22.0,Drug resistance,6,16798952
1,22.0,Malignant neoplasm progression,6,16798952
0,22.1,Hair colour changes,3,16798976
1,22.1,Alopecia,3,16798976
2,22.1,Anxiety,6,16798976
3,22.1,Hair disorder,3,16798976
4,22.1,Hair texture abnormal,3,16798976
5,22.1,Madarosis,3,16798976
0,22.1,Hair disorder,3,16798979
1,22.1,Depression,6,16798979
2,22.1,Alopecia,3,16798979
3,22.1,Hair texture abnormal,3,16798979
4,22.1,Anxiety,6,16798979
5,22.1,Hair colour changes,3,16798979
0,22.0,Malaise,6,16799006
0,22.1,Stress,6,16799007
0,22.0,Neoplasm progression,6,16799011
0,22.0,Memory impairment,6,16799020
0,22.0,Immune system disorder,6,16799021
1,22.0,White blood cell count decreased,6,16799021
0,22.0,Infusion related reaction,6,16799037
1,22.0,Oxygen saturation decreased,6,16799037
2,22.0,Throat irritation,6,16799037
3,22.0,Dyspnoea,6,16799037
0,22.0,Alopecia,3,16799071
1,22.0,Madarosis,3,16799071
0,22.1,Alopecia,3,16799076
1,22.1,Hair disorder,3,16799076
2,22.1,Madarosis,3,16799076
3,22.1,Hair texture abnormal,3,16799076
4,22.1,Hair colour changes,3,16799076
0,22.0,Colitis,6,16799077
0,22.0,Abdominal distension,1,16799083
1,22.0,Abdominal pain,1,16799083
0,22.1,Blood pressure increased,3,16799086
1,22.1,Asthenia,2,16799086
2,22.1,Rash,3,16799086
3,22.1,Decreased appetite,3,16799086
4,22.1,Pruritus,3,16799086
5,22.1,Weight increased,3,16799086
6,22.1,Hypertension,3,16799086
7,22.1,Thyroid hormones decreased,3,16799086
8,22.1,Dehydration,3,16799086
9,22.1,Thyroid disorder,2,16799086
0,22.0,Febrile neutropenia,5,16799190
1,22.0,Sepsis,5,16799190
2,22.0,Pneumonia,5,16799190
3,22.0,Off label use,6,16799190
0,22.1,Pneumothorax,1,16799269
0,22.1,Cholangitis,1,16799339
1,22.1,Liver disorder,2,16799339
0,22.0,Hepatitis fulminant,5,16799358
0,22.0,Pain in extremity,2,16799376
1,22.0,Neoplasm progression,3,16799376
2,22.0,Lymphadenopathy,3,16799376
3,22.0,Oedema peripheral,2,16799376
0,22.0,Hypertriglyceridaemia,1,16799414
0,22.0,Neoplasm progression,2,16799416
1,22.0,Hypersensitivity,6,16799416
0,22.0,Sepsis,5,16799443
1,22.0,Haematotoxicity,5,16799443
0,22.0,Death,5,16799493
0,22.0,Vomiting,6,16799500
1,22.0,Urinary tract infection,6,16799500
2,22.0,Platelet count decreased,3,16799500
3,22.0,Respiratory tract infection,6,16799500
0,22.0,Septic shock,2,16799504
1,22.0,Bone marrow failure,2,16799504
2,22.0,Somnolence,2,16799504
3,22.0,Hepatic function abnormal,2,16799504
4,22.0,Vaginal haemorrhage,2,16799504
0,22.0,Death,5,16799512
0,22.0,Intestinal perforation,6,16799519
1,22.0,Blood glucose increased,6,16799519
0,22.0,Death,5,16799525
0,22.0,Metastases to breast,6,16799530
1,22.0,Lymphadenopathy,6,16799530
2,22.0,Gastrointestinal infection,6,16799530
3,22.0,Abdominal pain,6,16799530
4,22.0,Duodenal obstruction,6,16799530
5,22.0,Eating disorder,6,16799530
6,22.0,Abdominal distension,6,16799530
7,22.0,Pancreatic disorder,6,16799530
8,22.0,Malaise,6,16799530
9,22.0,Drug ineffective,6,16799530
10,22.0,Spinal pain,6,16799530
11,22.0,Metastases to neck,6,16799530
12,22.0,Abdominal discomfort,6,16799530
13,22.0,Metastases to spine,6,16799530
14,22.0,Drug-induced liver injury,6,16799530
15,22.0,Vomiting,3,16799530
16,22.0,Hiccups,6,16799530
17,22.0,Hyperhidrosis,6,16799530
18,22.0,Decreased immune responsiveness,6,16799530
0,22.0,Torsade de pointes,1,16799535
0,22.0,Rectal haemorrhage,6,16799542
0,22.0,Acute kidney injury,6,16799554
1,22.0,Blood creatinine increased,2,16799554
0,22.0,Hypoaesthesia,1,16799564
1,22.0,Erythema,1,16799564
2,22.0,Dyspnoea,1,16799564
3,22.0,Asthenia,1,16799564
0,22.1,Dyspnoea,6,16799570
1,22.1,Pericardial effusion,6,16799570
2,22.1,Pleural effusion,6,16799570
3,22.1,Vomiting,6,16799570
0,22.0,Drug ineffective,6,16799573
1,22.0,Pulmonary oedema,6,16799573
0,22.0,Renal failure,6,16799588
1,22.0,Product use in unapproved indication,6,16799588
0,22.0,Death,5,16799596
0,22.1,Alopecia,6,16799609
0,22.0,Cerebrovascular accident,5,16799625
0,22.1,Cancer surgery,,16799743
0,22.1,Haemorrhage,6,16799758
1,22.1,Eastern Cooperative Oncology Group performance status worsened,6,16799758
2,22.1,Hepatotoxicity,1,16799758
3,22.1,Visual impairment,6,16799758
4,22.1,Pulmonary embolism,1,16799758
5,22.1,Headache,6,16799758
6,22.1,Rash,6,16799758
7,22.1,Haemoptysis,6,16799758
8,22.1,Dyspnoea,6,16799758
9,22.1,Vomiting,6,16799758
10,22.1,Embolism venous,6,16799758
11,22.1,Deep vein thrombosis,1,16799758
0,22.0,Neoplasm progression,6,16799768
1,22.0,Blindness,6,16799768
2,22.0,Somnolence,6,16799768
0,22.0,Haemorrhage,1,16799783
1,22.0,Tumour haemorrhage,1,16799783
2,22.0,Mobility decreased,1,16799783
0,22.0,Neutropenia,6,16799785
1,22.0,Joint swelling,6,16799785
2,22.0,Ear swelling,6,16799785
3,22.0,Thrombocytopenia,6,16799785
4,22.0,Rash,6,16799785
5,22.0,Pyrexia,6,16799785
0,22.1,Asthenia,6,16799790
1,22.1,Leukopenia,1,16799790
2,22.1,Anaemia,3,16799790
3,22.1,Neoplasm progression,1,16799790
4,22.1,Fatigue,3,16799790
5,22.1,Neutropenia,1,16799790
0,22.1,Intervertebral disc degeneration,3,16799791
1,22.1,Body height decreased,3,16799791
2,22.1,Renal failure,1,16799791
0,22.0,Off label use,6,16799793
1,22.0,Incorrect route of product administration,6,16799793
2,22.0,Palpitations,2,16799793
3,22.0,Dizziness,2,16799793
4,22.0,Tachycardia,2,16799793
0,22.1,Disease progression,,16799815
0,22.0,Drug ineffective,6,16799851
0,22.0,Laboratory test abnormal,6,16799855
0,22.0,Fatigue,6,16799861
1,22.0,Rash,6,16799861
2,22.0,Chest pain,6,16799861
3,22.0,Dizziness,6,16799861
4,22.0,Nausea,6,16799861
5,22.0,Nausea,6,16799861
6,22.0,Vomiting,6,16799861
7,22.0,Vomiting,6,16799861
0,22.0,Chest discomfort,6,16799864
1,22.0,Abdominal pain,6,16799864
2,22.0,Nausea,6,16799864
3,22.0,Flatulence,6,16799864
0,22.0,Abdominal discomfort,6,16799866
1,22.0,Decreased appetite,6,16799866
2,22.0,Fatigue,6,16799866
0,22.0,Prostatic specific antigen increased,3,16799868
1,22.0,Drug ineffective,6,16799868
0,22.0,Asthenia,6,16799870
0,22.0,Dizziness,1,16799871
1,22.0,Sinusitis,1,16799871
0,22.0,Malignant neoplasm progression,6,16799875
1,22.0,Drug resistance,6,16799875
0,22.1,Cardiac dysfunction,6,16799879
1,22.1,Pleural effusion,6,16799879
2,22.1,Metastases to central nervous system,6,16799879
3,22.1,Pseudomembranous colitis,6,16799879
4,22.1,Depressed level of consciousness,6,16799879
5,22.1,Interstitial lung disease,5,16799879
6,22.1,Cellulitis,6,16799879
7,22.1,Cardiac murmur,6,16799879
8,22.1,Cardiac failure chronic,6,16799879
0,22.0,Nausea,6,16799880
1,22.0,Oedema peripheral,6,16799880
2,22.0,Decreased appetite,6,16799880
3,22.0,Treatment noncompliance,6,16799880
0,22.0,Drug intolerance,6,16799881
0,22.0,Drug ineffective,3,16799882
0,22.0,Nausea,6,16799890
0,22.0,Somnolence,6,16799891
1,22.0,Treatment noncompliance,6,16799891
2,22.0,Fatigue,6,16799891
0,22.0,Drug ineffective,6,16799892
0,22.1,Disease progression,,16799894
0,22.0,Confusional state,6,16799900
1,22.0,Partial seizures,6,16799900
2,22.0,Intentional dose omission,6,16799900
3,22.0,Fall,6,16799900
0,22.0,Sinusitis,6,16799902
1,22.0,Nasopharyngitis,6,16799902
2,22.0,Hyperhidrosis,6,16799902
0,22.0,Fatigue,6,16799904
0,22.0,Feeling abnormal,6,16799906
1,22.0,Upper limb fracture,6,16799906
0,22.0,Decreased appetite,3,16799907
1,22.0,Nausea,3,16799907
0,22.0,Fatigue,3,16799908
1,22.0,Hot flush,3,16799908
0,22.0,Fatigue,3,16799909
1,22.0,Hot flush,3,16799909
0,22.0,Dysphagia,6,16799913
1,22.0,Retching,6,16799913
2,22.0,Vomiting,6,16799913
3,22.0,Product size issue,6,16799913
4,22.0,Product prescribing error,6,16799913
5,22.0,Inappropriate schedule of product administration,6,16799913
6,22.0,Wrong technique in product usage process,6,16799913
7,22.0,Foreign body in respiratory tract,6,16799913
0,22.0,Asthenia,6,16799915
1,22.0,Fatigue,6,16799915
2,22.0,Underdose,6,16799915
0,22.0,Fatigue,6,16799918
1,22.0,Nervousness,6,16799918
0,22.0,Product dose omission,6,16799920
0,22.0,Fatigue,6,16799922
0,22.0,Fatigue,3,16799925
0,22.0,Rash,3,16799927
0,22.0,Product dose omission,6,16799931
1,22.0,Prostatic specific antigen increased,6,16799931
0,22.0,Fall,1,16799932
1,22.0,Dysphagia,2,16799932
0,22.0,Rash,1,16799934
0,22.0,Diarrhoea,1,16799938
1,22.0,Pollakiuria,6,16799938
2,22.0,Restless legs syndrome,3,16799938
3,22.0,Insomnia,3,16799938
4,22.0,Constipation,2,16799938
5,22.0,Fatigue,2,16799938
6,22.0,Decreased appetite,1,16799938
0,22.0,Pain in extremity,1,16799939
1,22.0,Depressed mood,3,16799939
2,22.0,Fatigue,3,16799939
3,22.0,Headache,1,16799939
0,22.0,Bronchitis,6,16799940
0,22.0,Drug ineffective,6,16799941
0,22.1,Disease progression,,16799942
0,22.0,Drug ineffective,6,16799944
0,22.0,Somnolence,3,16799945
0,22.0,Abdominal discomfort,6,16799950
0,22.0,Paraesthesia,6,16799952
1,22.0,Insomnia,6,16799952
0,22.0,Urinary incontinence,3,16799953
0,22.0,Pain in extremity,6,16799954
1,22.0,Back pain,6,16799954
2,22.0,Fatigue,6,16799954
3,22.0,Inappropriate schedule of product administration,6,16799954
4,22.0,Muscle tightness,6,16799954
0,22.0,Muscle atrophy,3,16799957
1,22.0,Prostatic specific antigen increased,3,16799957
2,22.0,Asthenia,3,16799957
3,22.0,Fatigue,3,16799957
0,22.0,Confusional state,6,16799958
1,22.0,Decreased appetite,6,16799958
0,22.0,Gout,6,16799960
0,22.0,Dizziness,6,16799961
1,22.0,Diarrhoea,6,16799961
2,22.0,Blood pressure increased,6,16799961
0,22.0,Product dose omission,6,16799964
0,22.0,Dyspnoea,6,16799966
0,22.0,Hot flush,3,16799967
1,22.0,Musculoskeletal stiffness,3,16799967
2,22.0,Insomnia,3,16799967
0,22.0,Product dose omission,6,16799969
0,22.0,Diarrhoea,6,16799972
1,22.0,Pain,6,16799972
2,22.0,Decreased appetite,6,16799972
0,22.0,Prostatic specific antigen increased,6,16799973
0,22.0,Hot flush,3,16799975
1,22.0,Fatigue,3,16799975
0,22.0,Diarrhoea,6,16799977
0,22.0,Dysphagia,3,16799983
1,22.0,Product size issue,3,16799983
0,22.0,Peripheral swelling,3,16799984
0,22.0,Pollakiuria,3,16799986
0,22.0,Inappropriate schedule of product administration,6,16799991
1,22.0,Overdose,6,16799991
2,22.0,Product storage error,6,16799991
0,22.0,Rash,6,16799992
0,22.1,Disease progression,,16799993
0,22.0,Therapeutic product effect incomplete,6,16799994
0,22.0,Decreased appetite,6,16799995
1,22.0,Fatigue,6,16799995
0,22.0,Treatment noncompliance,3,16799996
0,22.0,Eye discharge,6,16799997
0,22.0,Product dose omission,6,16799999
0,22.0,Drug ineffective,6,16800001
0,22.0,Asthenia,3,16800002
1,22.0,Vomiting,6,16800002
0,22.0,Drug ineffective,6,16800003
1,22.0,Intentional dose omission,6,16800003
0,22.0,Underdose,6,16800005
0,22.0,Depressed level of consciousness,3,16800008
1,22.0,Night sweats,1,16800008
2,22.0,Pollakiuria,3,16800008
3,22.0,Hot flush,3,16800008
4,22.0,Decreased interest,3,16800008
5,22.0,Somnolence,3,16800008
6,22.0,Dizziness,3,16800008
0,22.0,Rash,6,16800010
0,22.0,Prostatic specific antigen increased,6,16800011
1,22.0,Sleep disorder,6,16800011
2,22.0,Back pain,3,16800011
3,22.0,Bone pain,3,16800011
0,22.0,Hot flush,3,16800013
1,22.0,Memory impairment,2,16800013
0,22.0,Prostatic specific antigen increased,6,16800014
1,22.0,Product dose omission,6,16800014
0,22.0,Nipple pain,3,16800015
1,22.0,Nipple pain,3,16800015
2,22.0,Hot flush,3,16800015
0,22.0,Inappropriate schedule of product administration,6,16800021
0,22.0,Hot flush,3,16800022
0,22.0,Pain,6,16800026
0,22.0,Peripheral swelling,3,16800028
1,22.0,Sleep disorder,3,16800028
2,22.0,Erectile dysfunction,3,16800028
3,22.0,Dyspnoea,3,16800028
4,22.0,Chills,3,16800028
5,22.0,Hot flush,3,16800028
0,22.0,Treatment noncompliance,3,16800030
1,22.0,Prescribed underdose,6,16800030
0,22.0,Nasopharyngitis,3,16800033
1,22.0,Fatigue,3,16800033
0,22.0,Hot flush,6,16800034
1,22.0,Skin discolouration,6,16800034
0,22.0,Fatigue,6,16800035
1,22.0,Tremor,6,16800035
2,22.0,Prostatic specific antigen increased,6,16800035
3,22.0,Asthenia,6,16800035
4,22.0,Anal incontinence,6,16800035
0,22.0,Vomiting,6,16800039
0,22.0,Intentional dose omission,6,16800041
0,22.0,Fatigue,6,16800043
0,22.0,Dizziness,3,16800045
1,22.0,Faeces soft,6,16800045
0,22.0,Taste disorder,6,16800047
1,22.0,Weight decreased,6,16800047
2,22.0,Prostatic specific antigen increased,6,16800047
3,22.0,Dry mouth,6,16800047
0,22.0,Drug ineffective,6,16800048
0,22.1,Fatigue,,16800049
1,22.1,Hot flush,,16800049
0,22.0,Urticaria,1,16800050
1,22.0,Rash pruritic,1,16800050
0,22.0,Rash,6,16800051
0,22.0,Diarrhoea,6,16800052
1,22.0,Constipation,6,16800052
2,22.0,Weight decreased,6,16800052
3,22.0,Abdominal distension,6,16800052
0,22.0,Product use in unapproved indication,6,16800053
0,22.0,Asthenia,3,16800056
0,22.0,Dysphagia,3,16800058
1,22.0,Bronchitis,6,16800058
0,22.0,Decreased appetite,3,16800059
1,22.0,Fatigue,3,16800059
2,22.0,Weight decreased,3,16800059
3,22.0,Hot flush,1,16800059
4,22.0,Asthenia,3,16800059
0,22.0,Bone disorder,3,16800066
0,22.0,Prostatic specific antigen increased,3,16800068
0,22.0,Vomiting,1,16800070
1,22.0,Abdominal pain upper,2,16800070
2,22.0,Drug intolerance,6,16800070
0,22.0,Inappropriate schedule of product administration,6,16800071
0,22.0,Fatigue,3,16800072
1,22.0,Initial insomnia,3,16800072
2,22.0,Abdominal discomfort,3,16800072
0,22.0,Product storage error,6,16800073
1,22.0,Product physical issue,6,16800073
2,22.0,Poor quality product administered,6,16800073
0,22.0,Hot flush,3,16800075
1,22.0,Nausea,3,16800075
0,22.0,Inappropriate schedule of product administration,6,16800077
1,22.0,Intentional underdose,6,16800077
0,22.0,Malaise,6,16800078
1,22.0,Gait inability,6,16800078
2,22.0,Somnolence,3,16800078
0,22.0,Dehydration,6,16800081
1,22.0,Nausea,6,16800081
2,22.0,Decreased appetite,6,16800081
3,22.0,Thinking abnormal,6,16800081
4,22.0,Gastrooesophageal reflux disease,6,16800081
5,22.0,Weight decreased,6,16800081
6,22.0,Night sweats,6,16800081
7,22.0,Feeding disorder,6,16800081
0,22.0,Drug ineffective,6,16800082
0,22.0,Dysphagia,6,16800087
0,22.0,Circumstance or information capable of leading to medication error,6,16800088
1,22.0,Memory impairment,6,16800088
0,22.0,Drug ineffective,6,16800089
0,22.0,Dyspnoea,6,16800091
1,22.0,Fall,6,16800091
0,22.0,Fatigue,6,16800096
0,22.0,Vomiting,1,16800100
1,22.0,Nausea,1,16800100
2,22.0,Headache,1,16800100
0,22.0,Hot flush,3,16800102
0,22.0,Feeling abnormal,2,16800103
1,22.0,Memory impairment,2,16800103
2,22.0,Peripheral coldness,1,16800103
3,22.0,Underdose,6,16800103
4,22.0,Hypokinesia,2,16800103
0,22.0,Drug ineffective,6,16800104
0,22.0,Underdose,6,16800107
1,22.0,Drug ineffective,6,16800107
0,22.0,Fatigue,6,16800113
1,22.0,Blood glucose decreased,6,16800113
2,22.0,Blood pressure increased,6,16800113
3,22.0,Hyperhidrosis,6,16800113
0,22.0,Circumstance or information capable of leading to medication error,6,16800116
1,22.0,Product odour abnormal,6,16800116
0,22.0,Nausea,6,16800118
0,22.0,Memory impairment,6,16800119
1,22.0,Product dose omission,6,16800119
0,22.0,Prostatic specific antigen increased,2,16800120
1,22.0,Tremor,2,16800120
2,22.0,Disorientation,2,16800120
3,22.0,Dizziness,2,16800120
4,22.0,Confusional state,2,16800120
5,22.0,Musculoskeletal discomfort,6,16800120
6,22.0,Asthenia,2,16800120
7,22.0,Decreased appetite,2,16800120
8,22.0,Hot flush,2,16800120
0,22.0,Myalgia,6,16800124
1,22.0,Asthenia,6,16800124
2,22.0,Malaise,6,16800124
3,22.0,Headache,6,16800124
4,22.0,Dizziness,6,16800124
0,22.0,Laryngitis,3,16800128
1,22.0,Upper-airway cough syndrome,3,16800128
2,22.0,Productive cough,3,16800128
3,22.0,Upper respiratory tract congestion,3,16800128
4,22.0,Oropharyngeal pain,3,16800128
5,22.0,Cough,3,16800128
0,22.0,Decreased appetite,6,16800130
0,22.0,Decreased appetite,3,16800131
1,22.0,Weight decreased,3,16800131
0,22.0,Abnormal faeces,3,16800133
1,22.0,Visual impairment,3,16800133
2,22.0,Breath odour,3,16800133
3,22.0,Flatulence,3,16800133
4,22.0,Confusional state,3,16800133
5,22.0,Lethargy,3,16800133
6,22.0,Hypoacusis,3,16800133
7,22.0,Feeling abnormal,3,16800133
8,22.0,Asthenia,3,16800133
9,22.0,Drug interaction,6,16800133
0,22.0,Faeces hard,6,16800135
1,22.0,Pain in extremity,6,16800135
2,22.0,Back pain,6,16800135
3,22.0,Headache,6,16800135
4,22.0,Hot flush,6,16800135
0,22.0,Decreased appetite,6,16800136
1,22.0,Taste disorder,6,16800136
0,22.0,Abdominal discomfort,6,16800138
1,22.0,Gastrooesophageal reflux disease,6,16800138
0,22.0,Injury,6,16800139
0,22.0,Prescribed underdose,6,16800140
0,22.0,Decreased appetite,6,16800142
1,22.0,Fatigue,6,16800142
2,22.0,Nausea,6,16800142
3,22.0,Taste disorder,6,16800142
0,22.0,Hyperhidrosis,3,16800143
0,22.0,Hyperhidrosis,3,16800144
1,22.0,Accidental overdose,6,16800144
0,22.0,Diarrhoea,6,16800145
1,22.0,Product dose omission,6,16800145
2,22.0,Vomiting,6,16800145
0,22.0,Fatigue,6,16800146
1,22.0,Inappropriate schedule of product administration,6,16800146
0,22.0,Rash,2,16800152
0,22.0,Product dose omission,6,16800153
0,22.0,Product use in unapproved indication,6,16800156
0,22.0,Product dose omission,6,16800157
1,22.0,Treatment noncompliance,6,16800157
2,22.0,Product supply issue,6,16800157
0,22.0,Generalised tonic-clonic seizure,1,16800158
1,22.0,Underdose,6,16800158
0,22.0,Product storage error,6,16800159
1,22.0,Underdose,6,16800159
0,22.0,Myalgia,6,16800162
1,22.0,Asthenia,6,16800162
2,22.0,Arthralgia,6,16800162
0,22.0,Product storage error,6,16800163
1,22.0,Product dose omission,6,16800163
2,22.0,Fatigue,6,16800163
0,22.0,Seizure,6,16800168
1,22.0,Fall,6,16800168
0,22.0,Weight decreased,6,16800169
1,22.0,Decreased appetite,6,16800169
2,22.0,Constipation,6,16800169
3,22.0,Nausea,6,16800169
0,22.0,Product size issue,6,16800170
1,22.0,Dysphagia,6,16800170
0,22.0,Fatigue,6,16800171
1,22.0,Asthenia,6,16800171
0,22.0,Treatment noncompliance,6,16800176
0,22.0,Upper limb fracture,6,16800178
1,22.0,Emotional disorder,6,16800178
2,22.0,Blood urine present,6,16800178
3,22.0,Fall,6,16800178
4,22.0,Asthenia,6,16800178
5,22.0,Fatigue,6,16800178
0,22.0,Vomiting,6,16800180
1,22.0,Gastrooesophageal reflux disease,6,16800180
2,22.0,Nausea,6,16800180
3,22.0,Drug interaction,6,16800180
0,22.0,Fatigue,6,16800181
1,22.0,Joint swelling,6,16800181
0,22.0,Decreased appetite,6,16800183
1,22.0,Myalgia,6,16800183
0,22.0,Headache,1,16800184
1,22.0,Erythema,6,16800184
2,22.0,Paraesthesia,6,16800184
3,22.0,Headache,6,16800184
4,22.0,Diarrhoea,6,16800184
